01
Collection
Capture the data — privacy-first defaults, granular consent.
- Experience log
- Opsy Concierge
- Scales & wearables
Ask the chat. Read the literature. Synthesized from thousands of peer-reviewed papers and clinical trials — with citations, every time.
What would you like to know about psychedelic research?
The literature reviews, the dataset layer, and the data feeds the chat is built on. Pick one — no scrolling required to compare.
Latest clinical trial evidence on psilocybin-assisted therapy for major depressive disorder.
Read review →Side-by-side: efficacy, durability, mechanism across MDMA-AT and psilocybin-AT.
Read review →What does evidence actually say? Separating signal from placebo.
Read review →Evidence since 2023 — dosing, durability, outcomes.
Read review →Flagship community-aggregated dataset — sample experience reports across six substances.
View details →RCT outcomes data with MADRS, BDI-II, MEQ30 across 12-month follow-up.
View details →Double-blind, placebo-controlled study of LSD/psilocybin microdosing on cognition.
View details →Peer-reviewed papers and clinical-trial records. Each chat answer is anchored with APA-style inline citations linking back to the source paper or trial entry.
Visit moreblossom.com →Community-curated substance and dosage information under CC-BY-SA 4.0. Used when the chat answers questions about specific compounds, doses, or interactions.
Visit psychonautwiki.org →Today you're using the analysis layer. The bigger arc: one open ecosystem where research data travels from contribution → insight → citable publication, without ever leaving the platform.
Capture the data — privacy-first defaults, granular consent.
Turn data and literature into answers, with citations.
Share findings — open, citable, consent-aware.
Whether you represent a research institution, TTO, clinical partner, or data contributor — we'd like to hear from you.
We've received your details. We'll be in touch based on your interests.